These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29158900)

  • 61. [Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome].
    Wu XL; Yu L; Long D; Yang JH; Zhang YC; Geng F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):478-81. PubMed ID: 21878172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients.
    Menges T; Hermans PW; Little SG; Langefeld T; Böning O; Engel J; Sluijter M; de Groot R; Hempelmann G
    Lancet; 2001 Apr; 357(9262):1096-7. PubMed ID: 11297964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer.
    Hofmann R; Lehmer A; Hartung R; Robrecht C; Buresch M; Grothe F
    J Urol; 1996 Mar; 155(3):858-62. PubMed ID: 8583593
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
    Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
    Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
    Shariat SF; Park S; Trinh QD; Roehrborn CG; Slawin KM; Karakiewicz PI
    J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test--ROTEM.
    Prakash S; Verghese S; Roxby D; Dixon D; Bihari S; Bersten A
    J Crit Care; 2015 Apr; 30(2):264-70. PubMed ID: 25454072
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.
    Duffy MJ; Duggan C
    Clin Biochem; 2004 Jul; 37(7):541-8. PubMed ID: 15234235
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*.
    Kager LM; Wiersinga WJ; Roelofs JJ; Meijers JC; Levi M; Van't Veer C; van der Poll T
    Crit Care Med; 2012 Jul; 40(7):2168-75. PubMed ID: 22564963
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of ascorbate on plasminogen activator inhibitor-1 expression and release from platelets and endothelial cells in an in-vitro model of sepsis.
    Swarbreck SB; Secor D; Ellis CG; Sharpe MD; Wilson JX; Tyml K
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):436-42. PubMed ID: 25730478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
    Fujii T; Obara T; Tanno S; Ura H; Kohgo Y
    Hepatogastroenterology; 1999; 46(28):2299-308. PubMed ID: 10521987
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
    Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
    J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
    [TBL] [Abstract][Full Text] [Related]  

  • 74. External pneumatic compression and fibrinolysis in abdominal surgery.
    Cahan MA; Hanna DJ; Wiley LA; Cox DK; Killewich LA
    J Vasc Surg; 2000 Sep; 32(3):537-43. PubMed ID: 10957661
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Short-term effect of ascorbate on bacterial content, plasminogen activator inhibitor-1, and myeloperoxidase in septic mice.
    Swarbreck SB; Secor D; Ellis CG; Sharpe MD; Wilson JX; Tyml K
    J Surg Res; 2014 Oct; 191(2):432-40. PubMed ID: 24814200
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.
    Chen D; Wu X; Yang J; Yu L
    Exp Ther Med; 2019 Oct; 18(4):2984-2992. PubMed ID: 31555383
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis.
    Texereau J; Pene F; Chiche JD; Rousseau C; Mira JP
    Crit Care Med; 2004 May; 32(5 Suppl):S313-9. PubMed ID: 15118537
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The clinical importance of a cytokine network in the acute phase of sepsis.
    Matsumoto H; Ogura H; Shimizu K; Ikeda M; Hirose T; Matsuura H; Kang S; Takahashi K; Tanaka T; Shimazu T
    Sci Rep; 2018 Sep; 8(1):13995. PubMed ID: 30228372
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
    Koyama K; Nunomiya S
    J Intensive Care; 2017; 5():63. PubMed ID: 29158900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.